← FDA DRUG APPROVALS

FDA ANDA · ANDA210215

AMANTADINE HYDROCHLORIDE

Sponsor: POM PHARMA

APPLICATION
ANDA210215
TYPE
ANDA
ORIGINAL APPROVAL
2020-03-10
LATEST ACTION
2026-05-13
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

AMANTADINE HYDROCHLORIDEPrescription
AMANTADINE HYDROCHLORIDE 100MG · TABLET · ORAL

Approval history

2026-05-13Labeling · Supplement 1 · standardAP
2020-03-10UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →